Dr. Friedrich Asmus appointed as CMO
Dr. Asmus brings two decades of experience leading global clinical and translational research programs for
Dr. Asmus brings two decades of experience leading global clinical and translational research programs for
Led by specialist life sciences investor, Forbion Investment will fund Phase 2 human clinical studies
Appointment builds Oxular’s team as it prepares to enter human clinical studies evaluating OXU-001 OXFORD,
Provides further momentum for OXU-003 development programme OXFORD, England, Oct. 12, 2020 – Oxular Limited (“Oxular”),
Oxular Limited Appoints Dr. Rafiq Hasan as Non-Executive Director OXFORD, UK, 5 October 2020 –
Prof. Marc de Smet joins Oxular Prof. de Smet is a retinal surgeon with more
Abingdon, UK, 7 October 2016 – OBN Ltd, the membership organisation supporting the UK’s innovative
V-Bio Ventures joins investment syndicate Completes oversubscribed £15.5 million Series A financing round Accelerates development
22 February 2016 – Imperial Innovations Group plc (AIM: IVO, ‘the Group’, ‘Innovations’) has led
Our Site
General Contact
+44 (0)1865 636200
Magdalen Centre
1 Robert Robinson Avenue
Oxford, OX4 4GA, UK
Media Contact
Ben Atwell / Alex Davis
FTI Consulting
London
Limited company registered in England and Wales (Registration No. 09331313)
VAT No. GB 244 5883 81
Copyright Oxular Limited
Website designed by Emerald Grove Studio
Website built by THRH Consulting
Follow us on
Limited company registered in England and Wales (Registration No. 09331313) VAT No. GB 244 5883 81
Copyright Oxular Limited
Website designed by Emerald Grove Studio
Website built by THRH Consulting